Parkwood LLC’s Cymabay Therapeutics CBAY Stock Holding History

Parkwood LLC’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,191	Closed	-$264K	–	206
2023 Q4	$264K	Buy	+11,191	New	+$199K	0.03%	121

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Parkwood LLC's CBAY Position: Q1 2024 in Review

Parkwood LLC sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 11,191 shares — an estimated $264K sold.

Parkwood LLC first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $264K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Parkwood LLC reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Parkwood LLC sold 11,191 Cymabay Therapeutics shares in Q1 2024, an estimated $264K.
Parkwood LLC first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
Parkwood LLC's Cymabay Therapeutics position peaked at $264K in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Parkwood LLC's 13F filing for Q1 2024, filed 15 May 2024.